Literature DB >> 15653480

Drug safety. Gaps in the safety net.

Jennifer Couzin.   

Abstract

Mesh:

Year:  2005        PMID: 15653480     DOI: 10.1126/science.307.5707.196

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  8 in total

Review 1.  Personalized medicine: a reality within this decade.

Authors:  Robert Roberts
Journal:  J Cardiovasc Transl Res       Date:  2008-01-26       Impact factor: 4.132

2.  Ethical issues in clinical trials involving nanomedicine.

Authors:  David B Resnik; Sally S Tinkle
Journal:  Contemp Clin Trials       Date:  2006-11-17       Impact factor: 2.226

3.  Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal.

Authors:  Maria T Herdeiro; Jorge Polónia; Juan J Gestal-Otero; Adolfo Figueiras
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

4.  Reforming direct-to-consumer advertising.

Authors:  Bryan A Liang; Tim Mackey
Journal:  Nat Biotechnol       Date:  2011-05       Impact factor: 54.908

5.  Postmarketing Research and Surveillance: Issues and Challenges.

Authors:  David B Resnik
Journal:  Monitor (Assoc Clin Pharmacol)       Date:  2008-04

6.  Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases.

Authors:  Stephanie J Reisinger; Patrick B Ryan; Donald J O'Hara; Gregory E Powell; Jeffery L Painter; Edward N Pattishall; Jonathan A Morris
Journal:  J Am Med Inform Assoc       Date:  2010 Nov-Dec       Impact factor: 4.497

7.  A secure distributed logistic regression protocol for the detection of rare adverse drug events.

Authors:  Khaled El Emam; Saeed Samet; Luk Arbuckle; Robyn Tamblyn; Craig Earle; Murat Kantarcioglu
Journal:  J Am Med Inform Assoc       Date:  2012-08-07       Impact factor: 4.497

8.  Beyond post-marketing research and MedWatch: Long-term studies of drug risks.

Authors:  David B Resnik
Journal:  Drug Des Devel Ther       Date:  2007-10-01       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.